ConvaTec Group PLC Director/PDMR Shareholding (8578Q)

TIDMCTEC

RNS Number : 8578Q

ConvaTec Group PLC

20 October 2023

20 October 2023

Convatec Group Plc

("Convatec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of GBP0.10 pence each in the share capital of the Company ("Shares").

On 19 October 2023, Constantin Coussios, Non-Executive Director and PDMR, purchased 4,977 Shares at an average price of GBP1.9953 per Share. Constantin Coussios' resulting shareholding is now a total of 23,278 Shares.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1       Details of the person discharging managerial responsibilities/person 
           closely associated 
  a)     Name                                             Constantin Coussios 
  2      Reason for the notification 
  a)     Position/Status                                  Non-Executive Director 
  b)     Initial notification/Amendment                   Initial notification 
  3      Details of the issuer, emission allowance market participant, 
          auction platform, auctioneer or auction monitor 
  a)     Name                                             Convatec Group Plc 
  b)     LEI                                              213800LS272L4FIDOH92 
  4      Details of the transaction(s): section to be repeated for 
          (i) each type of instrument; (ii) each type of transaction; 
          (iii) each date; and (iv) each place where transactions have 
          been conducted 
  a)     Description of the financial                     Ordinary shares of 10p each in Convatec Group Plc ("Shares") 
          instrument, type of instrument                   GB00BD3VFW73 
          Identification code 
  b)     Nature of the transaction                         Purchase of shares on 19 October 2023 
   c)     Price(s) and volume(s)                          Price(s)                                         Volume(s) 
                                                           GBP1.9884                                        2,497 
                                                           GBP2.0006                                        2,480 
                                                        -----------------------------------------------  ------------- 
  d)     Aggregated information 
          - Aggregated volume                               4,977 
          - Price                                           GBP9,926.62 *excluding dealing charges 
  e)     Date of the transaction                          2023-10-19 
  f)     Place of the transaction                         London Stock Exchange, Main Market (XLON) 
 
 

Enquiries

Kate Postans, VP Investor Relations [phone]

[e-mail]

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit www.convatecgroup.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFSSIALIFIV

(END) Dow Jones Newswires

October 20, 2023 10:49 ET (14:49 GMT)